针对艾滋病毒感染管理的结构化治疗中断
1Research Institute for Genetic and Human Therapy, Washington, DC, USA. rightpv@tin.it
JAMA
|December 26, 2001
概括
针对人类免疫缺陷病毒 (HIV) 的结构化治疗中断 (STI) 可能有利于急性感染,但对于慢性病例需要更多的研究. 对于艾滋病毒管理的性传播感染的长期疗效和安全性仍然不确定.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗逆转录病毒药物对于艾滋病毒治疗至关重要,但长期使用会带来挑战.
- 患者对持续治疗的坚持往往会被中断,导致各种结果.
- 目前正在探索结构化治疗中断 (STI) 作为一种潜在的管理策略.
研究的目的:
- 为艾滋病毒患者在临床环境中提供有关性传播感染的全面审查.
- 评估与STI相关的优势和潜在风险.
- 分析STI对病毒载量和免疫参数的影响.
主要方法:
- 在MEDLINE上搜索有关高活性抗逆转录病毒疗法和治疗中断的英语文章 (1999年1月至2001年8月).
- 优先考虑同行评审的来源和权威的会议摘要.
- 基于药物治疗方案,患者状态,中断频率/持续时间和临床结果的研究分析.
主要成果:
- 在免疫系统完好无损的急性艾滋病毒感染中,性传播感染可能更有益.
- 性传播感染对慢性艾滋病毒的长期管理,毒性和生活质量的影响尚未确定.
- 观察患者分类为急性感染,慢性抑制感染和病毒学失败场景.
结论:
- 在广泛采用STI之前,需要进一步的随机对照试验和强大的免疫状态评估.
- 在中断期间,治疗免疫或疫苗接种策略是长期控制艾滋病毒的首选.
- 性传播感染在治疗慢性艾滋病毒感染中的作用需要更明确的证据.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...


